A partner in the Paul, Weiss Litigation Department, Paul Paterson has substantial experience with a wide variety of matters in all phases of complex civil litigation. He has represented clients in bankruptcy, mergers and acquisitions, securities, ERISA, contractual and other complex commercial disputes. He has litigated high-profile cases in numerous jurisdictions and has substantial trial experience. He has also worked on multiple regulatory matters and internal investigations.
Lawdragon Honors
| Honor | Year | Practice |
|---|---|---|
| The 2027 Lawdragon 500 Leading Litigators in America | 2027 | Complex Litigation, Bankruptcy, M&A |
| The 2026 Lawdragon 500 Leading Litigators in America | 2026 | Complex Litigation, Bankruptcy, M&A |
Paterson’s recent experience includes representing:
- Revlon, a leading global beauty company, and certain of its subsidiaries in discovery, depositions and hearings related to their chapter 11 cases in the U.S. Bankruptcy Court for the Southern District of New York and as counsel to Revlon in its successful defense in an adversary proceeding by pre-petition lenders alleging breach of credit agreements and other claims, achieving complete dismissal of all claims against Revlon.
- Proterra, a publicly traded developer and producer of commercial electric vehicle technology, including proprietary battery systems, electric transit buses and turnkey charging solutions, in its chapter 11 cases in the U.S. Bankruptcy Court for the District of Delaware.
- Fresenius SE & Co., a German healthcare company, in a landmark post-trial ruling, affirmed by the Delaware Supreme Court, that Fresenius was justified in terminating a $4.8 billion merger agreement with Akorn Pharmaceuticals due to Akorn’s post-signing decline and Akorn’s breaches of FDA data integrity requirements, both constituting Material Adverse Events (MAE) under Delaware law. The decision was the first to find an MAE justified based on post-signing financial decline and other factors.
- Channel Medsystems, Inc., a medical device start-up, in a trial victory in the Delaware Court of Chancery over Boston Scientific Corporation, which had unsuccessfully sought to terminate its $250 million acquisition of Channel based on an alleged MAE.
- Advance, a privately-owned investment company, and several current and former officers and directors in a stockholder class action brought in the Delaware Court of Chancery asserting breach of fiduciary duty claims related to the $43 billion merger between AT&T’s WarnerMedia and Discovery Inc.
- Bain Capital in a shareholder class action alleging that Bain aided and abetted a breach of fiduciary duty by the former controlling stockholder of one of its portfolio companies.